Ultragenyx Pharmaceutical Inc.RARENASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-11.07%
Near historical average
Average (9y)
-10.23%
Historical baseline
Range
High:-2.09%
Low:-16.26%
CAGR
+17.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -11.07% | +25.4% |
| 2023 | -14.83% | +8.8% |
| 2022 | -16.26% | -125.1% |
| 2021 | -7.22% | -245.4% |
| 2020 | -2.09% | +86.4% |
| 2019 | -15.32% | -12.5% |
| 2018 | -13.61% | -4.5% |
| 2017 | -13.03% | -112.0% |
| 2016 | -6.15% | -128.7% |
| 2015 | -2.69% | - |